Literature DB >> 25322466

Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions.

Marion R Munk1, Jesse J Jung, Kristin Biggee, William R Tucker, H Nida Sen, Ursula Schmidt-Erfurth, Amani A Fawzi, Lee M Jampol.   

Abstract

PURPOSE: To report acute/subacute vision loss and paracentral scotomata in patients with idiopathic multifocal choroiditis/punctate inner choroidopathy due to large zones of acute photoreceptor attenuation surrounding the chorioretinal lesions.
METHODS: Multimodal imaging case series.
RESULTS: Six women and 2 men were included (mean age, 31.5 ± 5.8 years). Vision ranged from 20/20-1 to hand motion (mean, 20/364). Spectral domain optical coherence tomography demonstrated extensive attenuation of the external limiting membrane, ellipsoid and interdigitation zones, adjacent to the visible multifocal choroiditis/punctate inner choroidopathy lesions. The corresponding areas were hyperautofluorescent on fundus autofluorescence and were associated with corresponding visual field defects. Full-field electroretinogram (available in three cases) showed markedly decreased cone/rod response, and multifocal electroretinogram revealed reduced amplitudes and increased implicit times in two cases. Three patients received no treatment, the remaining were treated with oral corticosteroids (n = 4), oral acyclovir/valacyclovir (n = 2), intravitreal/posterior subtenon triamcinolone acetate (n = 3), and anti-vascular endothelial growth factor (n = 2). Visual recovery occurred in only three cases of whom two were treated. Varying morphological recovery was found in six cases, associated with decrease in hyperautofluorescence on fundus autofluorescence.
CONCLUSION: Multifocal choroiditis/punctate inner choroidopathy can present with transient or permanent central photoreceptor attenuation/loss. This presentation is likely a variant of multifocal choroiditis/punctate inner choroidopathy with chorioretinal atrophy. Associated changes are best evaluated using multimodal imaging.

Entities:  

Mesh:

Year:  2015        PMID: 25322466      PMCID: PMC4304934          DOI: 10.1097/IAE.0000000000000370

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  28 in total

Review 1.  White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease.

Authors:  Lee M Jampol; Kevin G Becker
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

2.  Idiopathic multifocal choroiditis: a comment on present and past nomenclature.

Authors:  Rohan W Essex; James Wong; Lee M Jampol; Jonathan Dowler; Alan C Bird
Journal:  Retina       Date:  2013-01       Impact factor: 4.256

3.  Multifocal choroiditis and panuveitis: immunomodulatory therapy.

Authors:  Shawkat Shafik Michel; Anthony Ekong; Stefanos Baltatzis; C Stephen Foster
Journal:  Ophthalmology       Date:  2002-02       Impact factor: 12.079

4.  Acute zonal occult outer retinopathy in the fellow eye 5 years after presentation of punctate inner choroidopathy.

Authors:  Kurenai Taira; Mitsuru Nakazawa; Yoshiko Takano; Takuya Ota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-29       Impact factor: 3.117

5.  Fundus autofluorescence imaging in multifocal choroiditis: beyond the spots.

Authors:  Michal Kramer; Ethan Priel
Journal:  Ocul Immunol Inflamm       Date:  2013-12-11       Impact factor: 3.070

6.  Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging.

Authors:  Richard F Spaide; Naomi Goldberg; K Bailey Freund
Journal:  Retina       Date:  2013 Jul-Aug       Impact factor: 4.256

7.  Retinal dysfunction in central serous retinopathy.

Authors:  E L Chuang; D M Sharp; F W Fitzke; C M Kemp; A L Holden; A C Bird
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

8.  Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992.

Authors:  J D Gass
Journal:  J Clin Neuroophthalmol       Date:  1993-06

9.  Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy.

Authors:  F G Holz; R Y Kim; S D Schwartz; C A Harper; J Wroblewski; G B Arden; A C Bird
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

10.  Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study.

Authors:  L J Howe; H Woon; E M Graham; F Fitzke; A Bhandari; J Marshall
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

View more
  6 in total

1.  Masqueraders of multiple evanescent white dot syndrome (MEWDS).

Authors:  Jonathan F Russell; Francesco Pichi; Nathan L Scott; Matthew J Hartley; Dugald Bell; Aniruddha Agarwal; Belinda Leong; Gary N Holland; K Bailey Freund; David Sarraf
Journal:  Int Ophthalmol       Date:  2019-12-02       Impact factor: 2.031

Review 2.  Idiopathic Multifocal Choroiditis.

Authors:  Ali Tavallali; Lawrence A Yannuzzi
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

3.  Parafoveal cone abnormalities and recovery on adaptive optics in posterior uveitis.

Authors:  Kristin Biggee; Michael J Gale; Travis B Smith; Eric B Suhler; Mark E Pennesi; Phoebe Lin
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-11

4.  Multifocal Choroiditis with Retinal Vasculitis, Optic Neuropathy, and Keratoconus in a Young Saudi Male.

Authors:  Yousef Dhafiri; Khalid Al Rubaie; Omar Kirat; William N May; Quan D Nguyen; Igor Kozak
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Apr-Jun

5.  Rapid progression of chorioretinal atrophy in punctate inner choroiditis: a case report.

Authors:  Yuka Kasuya; Yuji Inoue; Satoru Inoda; Yusuke Arai; Hidenori Takahashi; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  J Med Case Rep       Date:  2021-12-15

6.  Imageology features of different types of multifocal choroiditis.

Authors:  Juanjuan Li; Yunpeng Li; Hua Li; Liwei Zhang
Journal:  BMC Ophthalmol       Date:  2019-02-01       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.